BASIC2BEMISAL | NIFTY I BANKNIFTY | BTST 📶☺️👍

Welcome to our Telegram Channel You will get latest Stock Market updates on this Channel. सोचकर,समझकर, निवेश कर और कमाई भी। More info or Queries:- Whatsapp me👇👇👇 https://wa.me/+919821639494 Telegram @Sharma_vijay 👍Join Now Telegram channel:- 👉https://t.me/Basic2Bemisal 👍 To get Educational videos Subscribe YouTube Channel:- 👉https://youtube.com/channel/UCpxblLudnz3uQlXhDb9r3gA Open FREE Demat/Trading Account, 1st Year FREE AMC. Best Brokerage with us by clicking on link Below, (Choice Broking Pvt. Ltd.) Account Opening Link:- 👉https://jiffy.choicebroking.in/open.html?ref=NDAzNTU 👉अधिक जानकारी के लिए सम्पर्क करें:- 😊विजय शर्मा ☎️9821639494 Disclaimers:- I am not SEBI registered analyst and all Content posted is for educational purpose only.

Stocks In News HDFC Bank: Profit in Q4 grew 22.8 percent to Rs 10,055.2 crore YoY as provisions declined 29.4 percent in the same period. Net interest income rose 10.2 percent to Rs 18,873 crore, with credit growth of 20.8 percent and a deposits growth of 16.8 percent YoY. Asset quality improved with gross non-performing assets falling 9 bps sequentially to 1.17 percent and net NPAs declining 5 bps QoQ to 0.32 percent in the March quarter. Infosys: The country's second-largest IT services company recorded lower-than-expected earnings growth in March 2022 quarter, with profit falling 2.1 percent sequentially to Rs 5,686 crore on lower-than-expected revenue growth (up 1.3 percent QoQ) and a fall in operating margin, and dollar revenue growth of seven-tenth of a percent QoQ at $4,280 million. However, the revenue growth guidance for the current financial year at 13-15 percent over the previous year exceeded analysts' expectations, with operating profit margin forecast in the range of 21-23 percent. Windlas Biotech: The company received a certificate of good manufacturing practices (GMP) from the South African Health Products Regulatory Authority. The company had undergone an inspection-audit during September 20-29, 2021. Windlas can now start manufacturing and sell its products in South Africa market. The company also received zero critical observations for its plant-IV at Dehradun after European Union GMP inspection carried out by the National Institute of Pharmacy and Nutrition, Hungary during April 11-13. UltraTech Cement: Its UAE subsidiary, UltraTech Cement Middle East Investments (UCMEIL), has picked up a 29.39 percent stake in RAK Cement Company for White Cement and Construction Materials PSC (RAKWCT), a listed entity on Abu Dhabi and Kuwait stock exchanges. This is a strategic investment and the acquisition cost will be $101.1 million. Alkem Laboratories: The pharma company's Taloja unit has been cleared by the US health regulator as the unit has not received “Form 483” after inspection. The US FDA inspected the company's bioequivalence centre at Taloja in Maharashtra during April 11-14. Tata Power: BlackRock Real Assets, together with Mubadala, will invest Rs 4,000 crore ($525 million) for a 10.53 percent stake in the company's subsidiary Tata Power Renewables. The investment has taken a base equity valuation of the subsidiary to Rs 34,000 crore. Mahindra & Mahindra: The company has hiked the price of its vehicles by 2.5 percent. The price revision is a result of a continuous increase in prices of key commodities such as steel, aluminium and palladium, the company said. Jubilant Ingrevia: The company has received CDMO contract worth Rs 270 crore in specialty chemicals business from an "international customer". The contract is for three years. The company will supply two key GMP intermediates for one of the “patented drugs” of the innovator pharmaceutical customer. Commercial supplies of both these products will start from FY23.

Stocks In News HDFC Bank: Profit in Q4 grew 22.8 percent to Rs 10,055.2 crore YoY as provisions declined 29.4 percent in the same period. Net interest income rose 10.2 percent to Rs 18,873 crore, with credit growth of 20.8 percent and a deposits growth of 16.8 percent YoY. Asset quality improved with gross non-performing assets falling 9 bps sequentially to 1.17 percent and net NPAs declining 5 bps QoQ to 0.32 percent in the March quarter. Infosys: The country's second-largest IT services company recorded lower-than-expected earnings growth in March 2022 quarter, with profit falling 2.1 percent sequentially to Rs 5,686 crore on lower-than-expected revenue growth (up 1.3 percent QoQ) and a fall in operating margin, and dollar revenue growth of seven-tenth of a percent QoQ at $4,280 million. However, the revenue growth guidance for the current financial year at 13-15 percent over the previous year exceeded analysts' expectations, with operating profit margin forecast in the range of 21-23 percent. Windlas Biotech: The company received a certificate of good manufacturing practices (GMP) from the South African Health Products Regulatory Authority. The company had undergone an inspection-audit during September 20-29, 2021. Windlas can now start manufacturing and sell its products in South Africa market. The company also received zero critical observations for its plant-IV at Dehradun after European Union GMP inspection carried out by the National Institute of Pharmacy and Nutrition, Hungary during April 11-13. UltraTech Cement: Its UAE subsidiary, UltraTech Cement Middle East Investments (UCMEIL), has picked up a 29.39 percent stake in RAK Cement Company for White Cement and Construction Materials PSC (RAKWCT), a listed entity on Abu Dhabi and Kuwait stock exchanges. This is a strategic investment and the acquisition cost will be $101.1 million. Alkem Laboratories: The pharma company's Taloja unit has been cleared by the US health regulator as the unit has not received “Form 483” after inspection. The US FDA inspected the company's bioequivalence centre at Taloja in Maharashtra during April 11-14. Tata Power: BlackRock Real Assets, together with Mubadala, will invest Rs 4,000 crore ($525 million) for a 10.53 percent stake in the company's subsidiary Tata Power Renewables. The investment has taken a base equity valuation of the subsidiary to Rs 34,000 crore. Mahindra & Mahindra: The company has hiked the price of its vehicles by 2.5 percent. The price revision is a result of a continuous increase in prices of key commodities such as steel, aluminium and palladium, the company said. Jubilant Ingrevia: The company has received CDMO contract worth Rs 270 crore in specialty chemicals business from an "international customer". The contract is for three years. The company will supply two key GMP intermediates for one of the “patented drugs” of the innovator pharmaceutical customer. Commercial supplies of both these products will start from FY23.

Top 10 things to know before the market opens today https://www.moneycontrol.com/news/business/markets/top-10-things-to-know-before-the-market-opens-today-57-8352111.html Download moneycontrol app: http://m.moneycontrol.com/mom

NBFC big annoucement tomorrow expected 3-4 banking license to be issued Bajaj / MM / Poonawala groups